Trials / Completed
CompletedNCT01024452
Randomized Comparison of Warfarin Dosing Quality Between the Hamilton Nomogram and a Commercial Computer System
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,298 (actual)
- Sponsor
- Population Health Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized comparison of warfarin dosing quality between the Hamilton nomogram and a commercial computer system. Hypothesis: Mean TTR of patients managed with the commercial computer system is non-inferior to management with the validated Hamilton Nomogram.
Detailed description
Warfarin has a variable effect and many potential food and drug interactions. To have an optimal therapeutic effect the International Normalized Ratio (INR) needs to be maintained within the therapeutic target range. The time that a patient spends within the therapeutic target range is an intermediate quality indicator for patient outcomes and should be optimized. For this purpose, we use in our anticoagulation clinic the simple two-step Hamilton nomogram, which has been validated by Kim et al. who showed that the nomogram improved INR control for warfarin maintenance compared with expertise-based dosing in our anticoagulation clinic (see references). Computer systems are also known to outperform expertise-based dosing, but no direct comparison of a computer system with a simple nomogram has been assessed. In this single-center randomized controlled clinical trial we will compare the simple two-step Hamilton nomogram with the widely used computerized dosing management system DAWN AC regarding their effect on time in therapeutic range for patients on maintenance dosing with target range 2-3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DAWN AC | computerized dosing management system for anticoagulation clinics |
| DEVICE | Hamilton Nomogram | simple nomogram for warfarin maintenance dosing |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-12-02
- Last updated
- 2011-07-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01024452. Inclusion in this directory is not an endorsement.